Nauman Taj, MD
Psychiatry · Fort Collins, CONPI 1942516539
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by AbbVie at 57.1% of the total. 2025 is the largest year on record at $5,245, more than ten times the $468 reported in 2019. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $63.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$609
- Otsuka America Pharmaceutical, Inc.$381
- Alkermes, Inc.$332
- Teva Pharmaceuticals USA, Inc.$288
- plus $987 from 10 others
What the payments were for
- Speaking & faculty fees$4,50051%
- Food & beverage$4,40949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $5,088 |
| Neurocrine Biosciences, Inc. | 24 | $1,226 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $609 |
| Otsuka America Pharmaceutical, Inc. | 13 | $381 |
| Alkermes, Inc. | 12 | $332 |
| Teva Pharmaceuticals USA, Inc. | 9 | $288 |
| Vanda Pharmaceuticals Inc. | 10 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $174 |
| Johnson & Johnson | 5 | $171 |
| Axsome Therapeutics, Inc. | 4 | $125 |
| Lundbeck LLC | 5 | $121 |
| E.r. Squibb & Sons, L.L.C. | 3 | $67 |
| Sunovion Pharmaceuticals Inc. | 2 | $41 |
| Eisai Inc. | 2 | $39 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,909 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 14 | $113,625 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $19,739 |
| Clozapine | 123 | $10,439 |
| Chlorpromazine Hcl | 31 | $9,544 |
| Divalproex Sodium ErDivalproex Sodium | 43 | $5,861 |
| Valproic AcidValproic Acid (As Sodium Salt) | 47 | $4,972 |
| Aripiprazole | 93 | $4,843 |
| Lamotrigine | 198 | $2,555 |
| Duloxetine Hcl | 71 | $2,524 |
| Olanzapine | 84 | $2,379 |
| Lurasidone Hcl | 27 | $2,029 |
| Atropine Sulfate | 37 | $1,765 |
| Divalproex Sodium | 51 | $1,554 |
| Naltrexone Hcl | 14 | $1,244 |
| Quetiapine Fumarate | 51 | $942 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,226 | $113,62514 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $19 | $19,73913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Fort Collins
- Jillian BuschFort Collins$3K
- Tammas KellyFort Collins$2K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.